124 related articles for article (PubMed ID: 12091373)
1. The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia.
Teofili L; Pierconti F; Di Febo A; Maggiano N; Vianelli N; Ascani S; Rossi E; Pileri S; Leone G; Larocca LM; De Stefano V
Blood; 2002 Jul; 100(2):714-7. PubMed ID: 12091373
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.
Bock O; Schlué J; Mengel M; Büsche G; Serinsöz E; Kreipe H
J Pathol; 2004 May; 203(1):609-15. PubMed ID: 15095485
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia.
Mesa RA; Hanson CA; Li CY; Yoon SY; Rajkumar SV; Schroeder G; Tefferi A
Blood; 2002 Jun; 99(11):4131-7. PubMed ID: 12010817
[TBL] [Abstract][Full Text] [Related]
4. Analysis of thrombopoietin and c-mpl expression in a child with essential thrombocythemia.
Yoshida N; Ishii E; Koga N; Kamimura T; Miyazaki S
Pediatr Hematol Oncol; 1998; 15(4):359-63. PubMed ID: 9658438
[TBL] [Abstract][Full Text] [Related]
5. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.
Taksin AL; Couedic JP; Dusanter-Fourt I; Massé A; Giraudier S; Katz A; Wendling F; Vainchenker W; Casadevall N; Debili N
Blood; 1999 Jan; 93(1):125-39. PubMed ID: 9864154
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis.
Tefferi A; Yoon SY; Li CY
Blood; 2000 Jul; 96(2):771-2. PubMed ID: 10887148
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels.
Goerttler PL; März E; Johansson PL; Andreasson B; Kutti J; Moliterno AR; Marchioli R; Spivak JL; Pahl HL;
Haematologica; 2005 Jun; 90(6):851-3. PubMed ID: 15951300
[TBL] [Abstract][Full Text] [Related]
8. Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates.
Yoon SY; Li CY; Tefferi A
Eur J Haematol; 2000 Sep; 65(3):170-4. PubMed ID: 11007052
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.
Elliot MA; Yoon SY; Kao P; Li CY; Tefferi A
Eur J Haematol; 2002 Mar; 68(3):175-9. PubMed ID: 12068799
[TBL] [Abstract][Full Text] [Related]
10. Functional roles of thrombopoietin-c-mpl system in essential thrombocythemia.
Matsumura I; Horikawa Y; Kanakura Y
Leuk Lymphoma; 1999 Jan; 32(3-4):351-8. PubMed ID: 10037033
[TBL] [Abstract][Full Text] [Related]
11. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia.
Horikawa Y; Matsumura I; Hashimoto K; Shiraga M; Kosugi S; Tadokoro S; Kato T; Miyazaki H; Tomiyama Y; Kurata Y; Matsuzawa Y; Kanakura Y
Blood; 1997 Nov; 90(10):4031-8. PubMed ID: 9354672
[TBL] [Abstract][Full Text] [Related]
12. Defective response to thrombopoietin and impaired expression of c-mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopenia.
Muraoka K; Ishii E; Tsuji K; Yamamoto S; Yamaguchi H; Hara T; Koga H; Nakahata T; Miyazaki S
Br J Haematol; 1997 Feb; 96(2):287-92. PubMed ID: 9029014
[TBL] [Abstract][Full Text] [Related]
13. Study of the thrombopoitin receptor in essential thrombocythemia.
Kiladjian JJ; Elkassar N; Hetet G; Briere J; Grandchamp B; Gardin C
Leukemia; 1997 Nov; 11(11):1821-6. PubMed ID: 9369413
[TBL] [Abstract][Full Text] [Related]
14. Normal thrombopoietin and its receptor (c-mpl) genes in children with essential thrombocythemia.
Randi ML; Putti MC; Pacquola E; Luzzatto G; Zanesco L; Fabris F
Pediatr Blood Cancer; 2005 Jan; 44(1):47-50. PubMed ID: 15390356
[TBL] [Abstract][Full Text] [Related]
15. A possible role for thrombopoietin and its receptor c-mpl in the pathobiology of essential thrombocythemia.
Griesshammer M; Bangerter M; Schrezenmeier H
Semin Thromb Hemost; 1997; 23(5):419-23. PubMed ID: 9387200
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.
Kuwana M; Okazaki Y; Kajihara M; Kaburaki J; Miyazaki H; Kawakami Y; Ikeda Y
Arthritis Rheum; 2002 Aug; 46(8):2148-59. PubMed ID: 12209520
[TBL] [Abstract][Full Text] [Related]
17. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia.
Yan L; Elkassar N; Gardin C; Briere J
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():31-40. PubMed ID: 8951770
[TBL] [Abstract][Full Text] [Related]
18. Proto-oncogene c-mpl is involved in spontaneous megakaryocytopoiesis in myeloproliferative disorders.
Li Y; Hetet G; Kiladjian JJ; Gardin C; Grandchamp B; Briere J
Br J Haematol; 1996 Jan; 92(1):60-6. PubMed ID: 8562412
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of thrombopoietin receptors on human megakaryocytes.
Kuwaki T; Hagiwara T; Yuki C; Kodama I; Kato T; Miyazaki H
FEBS Lett; 1998 May; 427(1):46-50. PubMed ID: 9613597
[TBL] [Abstract][Full Text] [Related]
20. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
Tong W; Lodish HF
J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
